Evidence map›Paper›PMID 35079440›Full record

ArticleJournal of gastric cancer2021

Predictive Significance of Promoter DNA Methylation of

Yo Kubota, Satoshi Tanabe, Mizutomo Azuma, Kazue Horio, Yoshiki Fujiyama, Takafumi Soeno, Yasuaki Furue, Takuya Wada, Akinori Watanabe, Kenji Ishido and 4 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of gastric cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Role ofBiomedicines · 2024
    Review
  5. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Yo KubotaDepartment of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.ORCID https://orcid.org/0000-0002-4050-396X
Satoshi TanabeDivision of Therapeutic Endoscopy, Department of Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Japan.ORCID https://orcid.org/0000-0002-9207-5637
Mizutomo AzumaDepartment of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.
Kazue HorioDepartment of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.
Yoshiki FujiyamaDivision of Advanced Surgical Oncology, Department of Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Japan.
Takafumi SoenoDivision of Advanced Surgical Oncology, Department of Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Japan.
Yasuaki FurueDepartment of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.ORCID https://orcid.org/0000-0001-7662-6358
Takuya WadaDepartment of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.ORCID https://orcid.org/0000-0001-5500-4242
Akinori WatanabeDepartment of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.
Kenji IshidoDepartment of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.ORCID https://orcid.org/0000-0002-6434-2902
Chikatoshi KatadaDepartment of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.ORCID https://orcid.org/0000-0002-2713-4661
Keishi YamashitaDivision of Advanced Surgical Oncology, Department of Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Japan.ORCID https://orcid.org/0000-0002-8492-0300
Wasaburo KoizumiDepartment of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.ORCID https://orcid.org/0000-0001-9972-1083
Chika KusanoDepartment of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.ORCID https://orcid.org/0000-0002-3789-4787
Kitasato University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePromoter DNA methylation of various genes has been associated with metachronous gastric cancer (MGC). The cancer-specific methylation gene, MATERIALS AND

methods

resultsIn the nMGC group, the TaqMeth values for T were significantly higher than that for TAM (P=0.0006). In the MGCSE groups, TAM (MGCSE-1) exhibited significantly higher TaqMeth values than TAM (nMGC) (P<0.0001) and TAM (MGCSE-2) (P=0.0041), suggesting that TAM (MGCSE-1) exhibited

conclusions

Indexed as

Cysteine dioxygenaseEarly gastric cancerEndoscopic submucosal dissectionMethylation

Identifiers

PMID35079440
PMCPMC8753284
OpenAlexW4205459838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.